Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire – IUGA-Revised in Refractory Overactive Bladder: Sacral Neuromodulation v. Botulinum Toxin Assessment

Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire – IUGA-Revised, CSV
Study Description
The purpose of this randomized, open-label, active-control trial was to compare the effectiveness of intra-detrusor botulinum toxin A (Botox A®, Allergan) versus sacral neuromodulation (InterStim®, Medtronic) for the treatment of refractory urge urinary incontinence. In addition, the study evaluated select technical attributes of the interventions as well as the effect of these two interventions on other lower urinary tract and pelvic floor symptoms. Non-pregnant adult females at least 21 years old with refractory urinary urge incontinence